Genovis AB (publ.) (GENO) — Capital Reinvestment Ratio
Genovis AB (publ.) (GENO) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr15.90 Million) in capital expenditures (Skr15.90 Million). Check how tangible is Genovis AB (publ.)'s equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genovis AB (publ.) Capital Reinvestment Ratio (2019–2025)
This chart tracks Genovis AB (publ.)'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see GENO operating cash flow.
Annual Capital Reinvestment Ratio for Genovis AB (publ.) (2019–2025)
Year-by-year Capital Reinvestment Ratio for Genovis AB (publ.) from 2019 to 2025. See Genovis AB (publ.) free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr32.02 Million | Skr32.02 Million | ▲ +3314.5% |
| 2024 | 0.03x | Skr37.12 Million | Skr1.09 Million | ▼ -84.5% |
| 2023 | 0.19x | Skr67.75 Million | Skr12.81 Million | ▲ +93.3% |
| 2021 | 0.10x | Skr45.92 Million | Skr4.49 Million | ▼ -98.2% |
| 2020 | 5.44x | Skr3.76 Million | Skr20.43 Million | ▲ +1285.5% |
| 2019 | 0.39x | Skr13.13 Million | Skr5.15 Million | — |